[Thrombocytopenia due to omalizumab]

An Pediatr (Barc). 2014 Jun;80(6):413-4. doi: 10.1016/j.anpedi.2013.10.031. Epub 2013 Nov 15.

[Article in Portuguese]

Authors

J A Lopez-Rodriguez¹, L Santos Franco²

Affiliations

¹ Centro de Salud Las Calesas, Urgencias de Pediatría, Hospital 12 de Octubre, Madrid, España. Electronic address: lopezrodriguezj@gmail.com.
² Centro de Salud General Ricardos, Urgencias de Pediatría Hospital 12 de Octubre, Madrid, España.

PMID: 24246236
DOI: 10.1016/j.anpedi.2013.10.031

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anti-Asthmatic Agents / adverse effects*
Antibodies, Anti-Idiotypic / adverse effects*
Antibodies, Monoclonal, Humanized / adverse effects*
Child
Female
Humans
Omalizumab
Thrombocytopenia / chemically induced*

Substances

Anti-Asthmatic Agents
Antibodies, Anti-Idiotypic
Antibodies, Monoclonal, Humanized
Omalizumab